123 related articles for article (PubMed ID: 2419596)
1. [A case of amylase-producing ovarian tumor].
Tanaka Y; Ueda G; Tanizawa O; Miyake H; Kohno M; Nishiyama S; Inoue H; Ikeuchi H; Sekigawa S; Matsunaga S
Gan No Rinsho; 1986 Jan; 32(1):111-6. PubMed ID: 2419596
[TBL] [Abstract][Full Text] [Related]
2. [Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report].
Kawamurra S; Hiura M; Kaneko H; Yokoyama T; Tanaka M; Chiba T; Moriwaki S
Gan No Rinsho; 1988 Apr; 34(4):497-504. PubMed ID: 2451762
[TBL] [Abstract][Full Text] [Related]
3. [Neoplasm of the ovary as a cause of hyperamylasemia].
Pose Reino A; Suárez Dono J; Codesido Blanco T; Ferrón Vidán F; Lorenzo González A; Bugallo Paz L
An Med Interna; 1989 Apr; 6(4):207-8. PubMed ID: 2485076
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic brain tumor after chemotherapy of ovarian cancer].
Fukuda K; Chen JT; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K; Sakamoto A
Gan No Rinsho; 1987 Jan; 33(1):115-8. PubMed ID: 3102810
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and pathological studies on amylase-producing ovarian cancer].
Matsuda M; Izutsu T; Kagabu T; Nishiya I; Iida H; Kubota T
Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):935-42. PubMed ID: 2414384
[No Abstract] [Full Text] [Related]
6. An amylase-producing serous cystadenocarcinoma of the ovary.
Hodes ME; Sisk CJ; Karn RC; Ehrlich CE; Lehrner LM; Roth LM; Morley DJ; Merritt AD
Oncology; 1985; 42(4):242-7. PubMed ID: 2409494
[TBL] [Abstract][Full Text] [Related]
7. [Effects of chemotherapy of advanced malignant ovarian tumors].
Ohta M; Sakakibara K; Casanova H; Nishida Y; Kano T; Tomoda Y; Kazato S; Miyazaki T; Arii Y; Umemura S
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2208-15. PubMed ID: 4062320
[TBL] [Abstract][Full Text] [Related]
8. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
Ohta M; Tomoda Y; Kano T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
[TBL] [Abstract][Full Text] [Related]
9. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia].
Nakamura S; Hirabayashi N; Asai J
Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341
[TBL] [Abstract][Full Text] [Related]
10. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
[TBL] [Abstract][Full Text] [Related]
11. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion].
Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504
[TBL] [Abstract][Full Text] [Related]
12. [A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil].
Tashiro K; Kondo N; Ikemoto I
Hinyokika Kiyo; 1986 Mar; 32(3):449-53. PubMed ID: 3728246
[TBL] [Abstract][Full Text] [Related]
13. [Rare late metastasis of a successfully treated advanced ovarian cancer].
Theissig P; Theissig F; Lotze W
Zentralbl Gynakol; 1986; 108(19):1189-92. PubMed ID: 3811669
[TBL] [Abstract][Full Text] [Related]
14. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
15. Amylase elevation attributable to an ovarian neoplasm.
Corlette MB; Dratch M; Sorger K
Gastroenterology; 1978 May; 74(5 Pt 1):907-9. PubMed ID: 640346
[TBL] [Abstract][Full Text] [Related]
16. Ovarian mucinous cystadenocarcinoma with sarcoma-appearing mural nodule of anaplastic carcinoma.
Tsuruchi N; Kaku T; Kinoshita H; Amada S; Saito T; Kamura T; Tsukamoto N; Nakano H
Gynecol Oncol; 1993 Aug; 50(2):259-63. PubMed ID: 8375741
[TBL] [Abstract][Full Text] [Related]
17. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
18. The alterations in the activity of amylase and its salivary isoenzyme in the serum of patients with ovarian carcinoma, submitted to radiotherapy.
Zakrzewska I; Pietryńczak M
Rocz Akad Med Bialymst; 1997; 42(1):229-35. PubMed ID: 9581485
[TBL] [Abstract][Full Text] [Related]
19. [A case of bilateral metastatic breast carcinoma from gastric carcinoma].
Kasuga Y; Senga O; Hanamura N; Iida F; Oota H; Katsuyama T; Tsuchiya S
Gan No Rinsho; 1986 Apr; 32(4):407-12. PubMed ID: 3012143
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
Cocconi G; DeLisi V; Di Blasio B
Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
